Cargando…
Ribociclib: a valuable addition to treatment options in breast cancer?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729298/ https://www.ncbi.nlm.nih.gov/pubmed/29302367 http://dx.doi.org/10.1136/esmoopen-2017-000246 |
| _version_ | 1783286164793327616 |
|---|---|
| author | Bartsch, Rupert |
| author_facet | Bartsch, Rupert |
| author_sort | Bartsch, Rupert |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5729298 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57292982018-01-04 Ribociclib: a valuable addition to treatment options in breast cancer? Bartsch, Rupert ESMO Open Editorial BMJ Publishing Group 2017-08-23 /pmc/articles/PMC5729298/ /pubmed/29302367 http://dx.doi.org/10.1136/esmoopen-2017-000246 Text en © European Society for Medical Oncology (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| spellingShingle | Editorial Bartsch, Rupert Ribociclib: a valuable addition to treatment options in breast cancer? |
| title | Ribociclib: a valuable addition to treatment options in breast cancer? |
| title_full | Ribociclib: a valuable addition to treatment options in breast cancer? |
| title_fullStr | Ribociclib: a valuable addition to treatment options in breast cancer? |
| title_full_unstemmed | Ribociclib: a valuable addition to treatment options in breast cancer? |
| title_short | Ribociclib: a valuable addition to treatment options in breast cancer? |
| title_sort | ribociclib: a valuable addition to treatment options in breast cancer? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729298/ https://www.ncbi.nlm.nih.gov/pubmed/29302367 http://dx.doi.org/10.1136/esmoopen-2017-000246 |
| work_keys_str_mv | AT bartschrupert ribociclibavaluableadditiontotreatmentoptionsinbreastcancer |